Soininen H - Search Results

1

Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.

Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group. Rosenberg A, et al. Among authors: soininen h. Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3. Alzheimers Res Ther. 2021. PMID: 33766132 Free PMC article. Clinical Trial.

2

Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory.

Soininen HS, Partanen K, Pitkänen A, Vainio P, Hänninen T, Hallikainen M, Koivisto K, Riekkinen PJ Sr. Soininen HS, et al. Neurology. 1994 Sep;44(9):1660-8. doi: 10.1212/wnl.44.9.1660. Neurology. 1994. PMID: 7936293

3

Apolipoprotein E, memory and Alzheimer's disease.

Soininen HS, Riekkinen PJ Sr. Soininen HS, et al. Trends Neurosci. 1996 Jun;19(6):224-8. doi: 10.1016/0166-2236(96)10027-8. Trends Neurosci. 1996. PMID: 8761956

4

Early diagnostic indices for the prevention of Alzheimer's disease.

Soininen HS, Scheltens P. Soininen HS, et al. Ann Med. 1998 Dec;30(6):553-9. doi: 10.3109/07853899809002604. Ann Med. 1998. PMID: 9920358 Free article. Review.

5

Hypertension and white matter lesions of the brain.

Kivipelto M, Soininen H, Tuomilehto J. Kivipelto M, et al. Among authors: soininen h. J Hypertens. 2002 Mar;20(3):387-9. doi: 10.1097/00004872-200203000-00011. J Hypertens. 2002. PMID: 11875303 Review. No abstract available.

6

Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.

Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. Among authors: soininen h. CNS Drugs. 2002;16(7):435-44. doi: 10.2165/00023210-200216070-00001. CNS Drugs. 2002. PMID: 12056919 Review.

7

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. Among authors: soininen h. Ann Intern Med. 2002 Aug 6;137(3):149-55. doi: 10.7326/0003-4819-137-3-200208060-00006. Ann Intern Med. 2002. PMID: 12160362

8

Lower Counts of Astroglia and Activated Microglia in Patients with Alzheimer's Disease with Regular Use of Non-Steroidal Anti-Inflammatory Drugs.

Alafuzoff I, Overmyer M, Helisalmi S, Soininen H. Alafuzoff I, et al. Among authors: soininen h. J Alzheimers Dis. 2000 Mar;2(1):37-46. doi: 10.3233/jad-2000-2105. J Alzheimers Dis. 2000. PMID: 12214109

9

Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease.

Pirskanen M, Hiltunen M, Mannermaa A, Iivonen S, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M, Soininen H, Alafuzoff I. Pirskanen M, et al. Among authors: soininen h. Dement Geriatr Cogn Disord. 2002;14(3):123-7. doi: 10.1159/000063603. Dement Geriatr Cogn Disord. 2002. PMID: 12218254

10

Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology.

Iivonen S, Helisalmi S, Mannermaa A, Alafuzoff I, Lehtovirta M, Soininen H, Hiltunen M. Iivonen S, et al. Among authors: soininen h. Neurosci Lett. 2003 Dec 4;352(2):146-50. doi: 10.1016/j.neulet.2003.08.041. Neurosci Lett. 2003. PMID: 14625044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters